Certified by Founder Lodge
Pendulum Therapeutics
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $12,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pendulum is committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases. Our targeted formulations of na
| Company | Date | Round | Raised |
|---|---|---|---|
 FLY BY JING |
March, 09 ,2023 | Series B | $12,000,000 |
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Revel(US) | $150,000,000 | (Feb 27, 2026)
Bluprynt | $4,250,000 | (Feb 27, 2026)
VITURE | $100,000,000 | (Feb 27, 2026)
ElastixAI | $18,000,000 | (Feb 27, 2026)
UpGuard | $75,000,000 | (Feb 27, 2026)
